Doctor profile · Federal record
Dr. Regina Chimileski, APRN
Family Nurse Practitioner (CMS: Nurse Practitioner) · Registered Nurse · Danbury, CT
- NPI 1598479586
- Accepts Medicare
- 3 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
25 Tamarack Ave
Danbury, CT 068114829
(203) 797-8990 - Additional location
-
24 Hospital Ave
Danbury, CT 068106099
(203) 739-7101
Credentials & registration
- NPI registered
- January 2023 — 3 yrs on file
- Profile last updated
- October 30, 2024
- Year of graduation
- 2023 — 3 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State licenses (2)
- Connecticut #12035 · Connecticut #146942
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1598479586. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
172
Distinct HCPCS
5
Medicare allowed
$6,560
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 85 | 16 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 36 | 36 | $81 | |
11102 |
Biopsy of related skin growth, first growth | 19 | 19 | $84 | |
17000 |
Destruction of precancer skin growth, 1 growth | 19 | 19 | $45 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 13 | 13 | $51 |
In context: peer comparison
Among 11 peers in Danbury Family Nurse Practitioner, average services per provider: 77. This provider delivers 2.2× the peer median.Open Payments
Industry payments received
All-time total
$3,639
Transactions
166
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 51 | $855.95 | |
| Ucb, INC. | 10 | $369.84 | |
| Incyte Corporation | 18 | $358.55 | |
| Sun Pharmaceutical Industries INC. | 11 | $316.92 | |
| Amgen INC. | 7 | $224.39 | |
| Dermavant Sciences, INC. | 14 | $217.71 | |
| Pfizer INC. | 14 | $215.17 | |
| Arcutis Biotherapeutics, INC. | 8 | $196.94 | |
| Leo Pharma INC. | 9 | $189.34 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $133.33 | |
| Novartis Pharmaceuticals Corporation | 5 | $108.18 | |
| Lilly USA, LLC | 5 | $107.63 | |
| Janssen Biotech, INC. | 3 | $88.38 | |
| Regeneron Healthcare Solutions, INC. | 3 | $81.42 | |
| Almirall LLC | 3 | $66.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
64
Patients
54
Total drug cost
$1,745
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 29 | 25 | $276 |
| Ketoconazole | Generic | 20 | 14 | $371 |
| Fluorouracil | Generic | 15 | 15 | $1,097 |
Hospital affiliations
Frequently asked questions
What is Dr. Regina Chimileski's medical specialty?
Dr. Regina Chimileski practices Family Nurse Practitioner in Danbury, CT.
Where does Dr. Regina Chimileski practice?
Dr. Regina Chimileski practices at 25 Tamarack Ave, Danbury, CT 068114829. Office phone: 2037978990.
What is Dr. Regina Chimileski's NPI?
Dr. Regina Chimileski's National Provider Identifier (NPI) is 1598479586, issued by NPPES.
Does Dr. Regina Chimileski accept Medicare assignment?
Yes. Dr. Regina Chimileski accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Regina Chimileski commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.